|
ZNF860 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50169987556126E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66530000011988E-07 |
| Normal-vs-Stage2 |
1.028430E-01 |
| Normal-vs-Stage3 |
4.444600E-01 |
| Normal-vs-Stage4 |
1.783560E-01 |
| Stage1-vs-Stage2 |
1.063390E-01 |
| Stage1-vs-Stage3 |
8.360200E-02 |
| Stage1-vs-Stage4 |
1.20120000002277E-06 |
| Stage2-vs-Stage3 |
6.793200E-01 |
| Stage2-vs-Stage4 |
3.674300E-02 |
| Stage3-vs-Stage4 |
2.197800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.46399994746827E-09 |
| Normal-vs-AfricanAmerican |
9.037500E-03 |
| Normal-vs-Asian |
6.457200E-01 |
| Caucasian-vs-AfricanAmerican |
1.042070E-02 |
| Caucasian-vs-Asian |
4.178800E-01 |
| AfricanAmerican-vs-Asian |
7.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.71669997609081E-09 |
| Normal-vs-Female |
7.844600E-04 |
| Male-vs-Female |
3.828000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.257980E-01 |
| Normal-vs-Extreme_Weight |
6.173300E-04 |
| Normal-vs-Obese |
2.028900E-04 |
| Normal-vs-Extreme_Obese |
1.985020E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.386000E-02 |
| Normal_Weight-vs-Obese |
7.692400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.658600E-01 |
| Extreme_Weight-vs-Obese |
9.858400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.227800E-01 |
| Obese-vs-Extreme_Obese |
4.457800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.287600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.36720000010993E-07 |
| Normal-vs-Age(61-80Yrs) |
1.91689999995415E-06 |
| Normal-vs-Age(81-100Yrs) |
1.172820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.990400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.824200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.154000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.081800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.300900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.148450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.11186623744197E-12 |
| Normal-VS-Type2 PRCC |
1.801640E-01 |
| Normal-VS-KIRP CIMP |
1.549550E-02 |
| Normal-VS-Unclassified PRCC |
4.875300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.448500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.98850000021622E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
4.087600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.544110E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.176200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.047800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.127620E-01 |
| Normal-vs-N1 |
9.649200E-01 |
| Normal-vs-N2 |
3.656300E-03 |
| N0-vs-N1 |
1.821240E-01 |
| N0-vs-N2 |
1.57761999999284E-05 |
| N1-vs-N2 |
4.245100E-04 |
|
|
